INSIGHT is conducting two international observational studies on the influenza virus: FLU 002 Plus (Respiratory Virus Outpatient Study) and FLU 003 Plus (Respiratory Virus Hospitalization Study). Additionally, INSIGHT is also conducting one international randomized double-blind placebo-controlled trial FLU-IVIG.

CHIP is coordinating the FLU Plus studies in 6 European countries; 

Belgium, Denmark, Estonia, Germany, Poland and Spain, and the FLU-IVIG study in Denmark and Spain.

For further details about the Influenza studies, please visit the INSIGHT website.